Related Experiment Video
Updated: Aug 12, 2026

Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
Children in medical research: balancing protection and access--has the pendulum swung too far?
1Department of Pediatrics, University of Chicago, IL 60637, USA. lross@uchicago.edu
Insights
Research policies for children shifted from protection to access between 1966 and 2003. This evolution requires careful monitoring to ensure child subject protections are not compromised by increased research access.
Area of Science:
- Medical Ethics
- Pediatric Research Policy
Background:
- Henry Beecher's 1966 publication highlighted unethical research, including studies involving child subjects.
- Ethical debates in the 1970s and 1980s led to initial U.S. policies for human subject protection, with specific safeguards (Subpart D) for vulnerable children.
Observation:
- A policy shift occurred in the 1990s, moving from child protection to ensuring broader access to research participation.
- New policies from NIH, FDA, and Congress reflected this change in focus.
Findings:
- The study analyzes the new policies, their underlying motivations, and their effects on pediatric research.
- The shift aimed to increase access for children in clinical research.
Implications:
- Increased access to research for children must be balanced with maintaining robust protections.
- Continued vigilance is necessary to prevent the erosion of safeguards for child research participants under Subpart D.
Abstract:
This paper examines the changes in policies regarding children in research between 1966 and 2003. The changes reflect a shift in focus from protection to access. The need for protection was brought to light in 1966, with the publication of Henry Beecher's "Ethics and Clinical Research," which described 22 research projects that he considered unethical. Four of these involved child subjects. Within a few years, Paul Ramsey and Richard McCormick debated the ethical acceptability of enrolling children in any non-therapeutic research. The first U.S. policies to address the protection of human subjects were written in the 1970s and 1980s, and additional protections (Subpart D) were provided to child subjects, who were considered particularly vulnerable. In the 1990s, however, several new policies were implemented by the National Institutes of Health, the Food and Drug Administration, and Congress, in which the focus had shifted from protecting children from research risks to ensuring access. The article describes the new policies, examines the motivations for the change, and describes some of the effects of these policies. It concludes by suggesting that greater attention must be paid to ensure that increased access is not achieved by undermining the additional protections to children provided by Subpart D.
More Related Videos
Related Concept Videos
CRISPR
Ethics in Research
Obedience
Blinding
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...

